Used in pharmaceutical research as a potent and selective inhibitor of soluble epoxide hydrolase (sEH), this compound plays a key role in modulating biological pathways involved in inflammation, pain, and cardiovascular regulation. Its primary application lies in the development of therapies for inflammatory diseases, neuropathic pain, hypertension, and metabolic disorders. By inhibiting sEH, it increases levels of endogenous epoxyeicosatrienoic acids (EETs), which have protective effects in vascular and renal systems. It is also employed as a reference compound in pharmacokinetic and pharmacodynamic studies due to its favorable metabolic stability and bioavailability in preclinical models.